Atlas Trials

A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients

Clinical trial NCT02323139 · COMPLETED

Trial details

NCT number
NCT02323139
Sponsor
Groupe Francophone des Myelodysplasies
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
MDS
Start date
2015-02-10
Primary completion
2018-01-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.